LIN and ATT, compounds from lotus and Artemisia, synergistically inhibit breast cancer cell growth and invasion by enhancing apoptosis and suppressing PI3K-AKT signaling. Promising potential for BC therapy.
Alpha-Hederin from ivy or black seed plants shows promise in treating non-small cell lung cancer by inhibiting mTOR, disrupting autophagy, and causing autophagic damage.
Endophytic fungi from medicinal plants produce bioactive compounds with potential for drug development. Aspergillus flavus showed antibiofilm and antioxidant activity, with compounds identified for anti-cancer properties. Further research is warranted on these promising findings.
Study on CHM use in EC patients with malnutrition in Taiwan. CHM commonly used but long-term impact unclear. Important for patient prognosis and treatment decisions.
Kaempferitrin in Chenopodium ambrosioides fights liver cancer by targeting specific pathways, verified in mice models. Important for developing treatments for liver cancer.
Researchers created Centella asiatica-derived nanovesicles (ADNVs) with anticancer properties through a simple process. ADNVs target diseases like cancer, show internalization in HepG2 cells, and impact metabolic pathways, suggesting their potential as effective anticancer agents.
Scientists studied the impact of Mespilus germanica leaf extract on cancer cells and healthy cells. Results show potential for cancer treatment without harming healthy cells.